FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and represents liquid dosage form of fenspiride hydrochloride in form of syrup, including fenspiride hydrochloride, methyl parahydroxybenzoate, propyl parahydroxybenzoate, potassium sorbate, sodium citrate, citric acid monohydrate, sodium saccharinate, noncrystallizing liquid sorbitol, glycerin, honey flavoring agent, fruit flavoring agent, dye E110 and purified water, wherein ingredients of the dosage form are taken in certain proportions, g/100 ml.
EFFECT: invention provides extending range of medications, which are liquid dosage forms of fenspiride hydrochloride, stable and long-term storable without use of sucrose.
2 cl, 14 dwg, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE ADDITIVE IN THE FORM OF A SYRUP WITH INCREASED MICROBIOLOGICAL RESISTANCE | 2018 |
|
RU2713303C2 |
| LIQUID PHARMACEUTICAL COMPOSITION OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2021 |
|
RU2783660C2 |
| LIQUID MEDICINAL FORM RISPERIDONE AND METHOD FOR ITS MANUFACTURE | 2016 |
|
RU2646812C1 |
| STABLE PHARMACEUTICAL COMPOSITION LAMIVUDINE | 2015 |
|
RU2587782C1 |
| LIQUID WATER PHARMACEUTICAL COMPOSITION OF AMBROXOL AND PHARMACEUTICAL PREPARATION BASED ON IT, INTENDED FOR TREATING DISEASES OF RESPIRATORY WAYS WITH FORMATION OF VISCOUS SPUTUM (VERSIONS) | 2010 |
|
RU2426531C1 |
| LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION, HAVING NOOTROPIC ACTIVITY | 2018 |
|
RU2703293C1 |
| ANTIHISTAMINE COMPOSITION | 2000 |
|
RU2165255C1 |
| LIQUID DOSAGE FORM FOR TREATMENT AND PREVENTION OF FLU AND ARVI | 2020 |
|
RU2770521C2 |
| LIQUID DOSAGE FORM FOR TREATING AND PREVENTING INFLUENZA AND ARVI | 2018 |
|
RU2737086C2 |
| LIQUID DOSAGE FORM FOR TREATING AND PREVENTING INFLUENZA AND SARS | 2020 |
|
RU2744854C1 |
